| Classification: |
Human Proteins |
| Catalog#: |
MK1370H |
| Product Name: |
Recombinant Human PTGDR2 Protein, VLP Platform |
| Description: |
CRTH2 is a prostaglandin D2 receptor expressed on Th2 cells, eosinophils, and basophils. It plays a key role in allergic inflammation and asthma. |
| Source: |
HEK293 cells |
| Species: |
Human |
| Tag: |
No |
| Formulation: |
115 mM Gly, 4% Trehalose |
| Proteinlength: |
Met1-Ser395 |
| Storage: |
For long term storage, the product should be stored at lyophilized state at -20 °C or lower. |
| Reconstitution: |
Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water. |
| Stability: |
Upon receiving, the product remains stable for 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. |
| Endotoxin: |
＜0.001 EU/μg |
| Concentration: |
1 mg/mL |
| Quality Control: |
Immobilized human PTGDR2 VLP binds to anti-GPR44/PTGDR2/CD294 reference antibody (KHK patent anti-CRTH2) with an EC50 of 0.1735 μg/mL. |
| Notes: |
Research Use Only. Not for use in clinical procedures. |
